Genmab A (GMAB) Revenue: 2018-2021
- Genmab A's Revenue rose 366933436.58% to $337.9 million in Q2 2021 from the same period last year, while for Jun 2021 it was $337.9 million, marking a year-over-year increase of 206.79%. This contributed to the annual value of -$1.4 billion for FY2024, which is 616.98% down from last year.
- According to the latest figures from Q2 2021, Genmab A's Revenue is $337.9 million, which was up 168,739,378.25% from $200.28 recorded in Q4 2020.
- In the past 5 years, Genmab A's Revenue registered a high of $337.9 million during Q2 2021, and its lowest value of $92.10 during Q2 2020.
- Over the past 3 years, Genmab A's median Revenue value was $200.28 (recorded in 2020), while the average stood at $76.4 million.
- Its Revenue has fluctuated over the past 5 years, first tumbled by 100.00% in 2019, then surged by 366,933,436.58% in 2021.
- Quarterly analysis of 4 years shows Genmab A's Revenue stood at $66.2 million in 2018, then crashed by 100.00% to $108.16 in 2019, then surged by 85.18% to $200.28 in 2020, then surged by 366,933,436.58% to $337.9 million in 2021.
- Its last three reported values are $337.9 million in Q2 2021, $200.28 for Q4 2020, and $92.10 during Q2 2020.
